The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
An agenda for personalized medicine
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Fourth, just as in psychometric measurement, genetic risk profiling can be error-prone [232].”
From Personality and Longevity: Knowns, Unknowns, and Implications for Public Health and Personalized Medicine (2011) · cites this paper as [232]
Citations
Cites
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C. A., SCOTT, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,236
Holmes, G. K. T., & Cooke, W. T. (1984) · Cited by 2,638
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
The NCBI dbGaP database of genotypes and phenotypes
Mailman, M. D., Feolo, M., Jin, Y., Kimura, M., Tryka, K. A., Bagoutdinov, R., Hao, L., Kiang, A., Paschall, J. E., Phan, L. D., et al. (2007) · Nature Genetics · doi:10.1038/ng1007-1181 · Cited by 1,100
Human genetic variation and its contribution to complex traits
Frazer, K. A., Murray, S. S., Schork, N. J., & Topol, E. J. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2554 · Cited by 1,073
Self-citationClinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts
Aulchenko, Y. S., Janssens, A. C. J. W., Albert Hofman, D., Isaacs, A. J., Sijbrands, E. J. G., Witteman, J. C. M., van Duijn, C. M., Ripatti, S., Lindqvist, I., Perola, M., et al. (2008) · Nature Genetics · doi:10.1038/ng.269 · Cited by 860
Genotype score in addition to common risk factors for prediction of type 2 diabetes
Meigs, J. B., Shrader, P., Sullivan, L. M., McAteer, J. B., Fox, C. S., Dupuis, J., Manning, A. K., Florez, J. C., Wilson, P. W. F., D'Agostino, R. B., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804742 · Cited by 759
Green, P. H., & Jabrì, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14027-5 · Cited by 730
Research works printed but not linked: 1
- Hsu, A. & Naughton, B. (eds) Guidelines on Vetting Genetic Associations (23andMe; 2008); available at https://23andme.https.internapcdn.net/res/4400/pdf/23-03_Vetting_Genetic_Associations.pdf
Cited by
Sorted by citations
Robson, M. E., Bradbury, A. R., Arun, B., Domchek, S. M., Ford, J. M., Hampel, H. L., Lipkin, S. M., Syngal, S., Wollins, D. S., & Lindor, N. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0996 · Cited by 949
The impact of next-generation sequencing on genomics
Zhang, J., Chiodini, R., Badr, A., & Zhang, G. (2011) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2011.02.003 · Cited by 577
“NGS technologies have increased the speed and throughput capacities of DNA sequencing and, as a result, dramatically reduced overall sequencing costs (Mardis, 2006, 2009; Schuster, 2008; Shendure and Ji, 2008; Ng et al., 2009a; Tucker et al., 2009; Metzker, 2010).”
BackgroundEffect of Direct-to-Consumer Genomewide Profiling to Assess Disease Risk
Bloss, C. S., Schork, N. J., & Topol, E. J. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011893 · Cited by 565
Intellectual Property Rights and Innovation: Evidence from the Human Genome
Williams, H. (2013) · Journal of Political Economy · doi:10.1086/669706 · Cited by 498
Berg, J. S., Khoury, M. J., & Evans, J. P. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318220aaba · Cited by 489
Genetics of Inflammatory Bowel Diseases
McGovern, D. P. B., Kugathasan, S., & Cho, J. H. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.001 · Cited by 446
Robson, M. E., Storm, C. D., Weitzel, J. N., Wollins, D. S., & Offit, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0660 · Cited by 429
Towards a comprehensive structural variation map of an individual human genome
Pang, A. W., MacDonald, J. R., Pinto, D., Wei, J., Rafiq, M. A., Conrad, D. F., Park, H., Hurles, M. E., Lee, C., Venter, J. C., et al. (2010) · Genome Biology · doi:10.1186/gb-2010-11-5-r52 · Cited by 335
Self-citationFenech, M. F., El‐Sohemy, A., Cahill, L. E., Ferguson, L. R., French, T.-A. C., Tai, E. S., Milner, J. A., Koh, W., Xie, L. Y., Zucker, M., et al. (2011) · Lifestyle Genomics · doi:10.1159/000327772 · Cited by 374
Graphene-Based Sensors for Human Health Monitoring
Huang, H., Su, S., Wu, N., Wan, H., Wan, S., Bi, H., & Sun, L. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00399 · Cited by 343
The molecular pathology of cancer
Harris, T., & McCormick, F. P. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.41 · Cited by 286
Chapman, B. P., Roberts, B., & Duberstein, P. (2011) · Journal of Aging Research · doi:10.4061/2011/759170 · Cited by 283
“Fourth, just as in psychometric measurement, genetic risk profiling can be error-prone [232].”
BackgroundGenetics, genomics, and cancer risk assessment
Weitzel, J. N., Blazer, K. R., MacDonald, D. J., Culver, J. O., & Offit, K. (2011) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.20128 · Cited by 255
CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point‐of‐Care Diagnosis
Dai, Y., Wu, Y., Liu, G., & Gooding, J. J. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202005398 · Cited by 244
The Emergence of Translational Epidemiology: From Scientific Discovery to Population Health Impact
Khoury, M. J., GWINN, M. L., & Ioannidis, J. P. A. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq211 · Cited by 249
The Brain-to-Brain Loop Concept for Laboratory Testing 40 Years After Its Introduction
Plebani, M., Laposata, M., & Lundberg, G. D. (2011) · American Journal of Clinical Pathology · doi:10.1309/ajcpr28hwhssdnon · Cited by 217
Personalizing medicine with clinical pharmacogenetics
Scott, S. A. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318238b38c · Cited by 211
Ko, T.-M., Tsai, C., Chen, S.-Y., Chen, K.-S., Yu, K., Chu, C., Huang, C.-M., Wang, C., Weng, C., Yu, C.-L., et al. (2015) · BMJ · doi:10.1136/bmj.h4848 · Cited by 212
Personalized medicine: new genomics, old lessons
Offit, K. (2011) · Human Genetics · doi:10.1007/s00439-011-1028-3 · Cited by 211
A review of flexible force sensors for human health monitoring
Cheng, M., Zhu, G., Zhang, F., Tang, W., Jianping, S., Yang, J., & Zhu, L. (2020) · Journal of Advanced Research · doi:10.1016/j.jare.2020.07.001 · Cited by 205
Xu, W., Jin, T., Dai, Y., & Liu, C.-C. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112100 · Cited by 195
Kaufman, D., Bollinger, J. M., Dvoskin, R. L., & Scott, J. A. (2012) · Journal of Genetic Counseling · doi:10.1007/s10897-012-9483-0 · Cited by 180
Gollust, S. E., Gordon, E. S., Zayac, C., Griffin, G., Christman, M. F., Pyeritz, R. E., Wawak, L., & Bernhardt, B. A. (2011) · Public Health Genomics · doi:10.1159/000327296 · Cited by 174
Cardiovascular disease: The rise of the genetic risk score
Knowles, J. W., & Ashley, E. A. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002546 · Cited by 182
An informatics approach to analyzing the incidentalome
Berg, J., Adams, M. C., Nassar, N., Bizon, C., Lee, K., Schmitt, C., Wilhelmsen, K., & Evans, J. P. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.112 · Cited by 175
Direct-to-consumer genetic testing
Horton, R., Crawford, G., Freeman, L., Fenwick, A., Wright, C. F., & Lucassen, A. (2019) · BMJ · doi:10.1136/bmj.l5688 · Cited by 151
Theranostic barcoded nanoparticles for personalized cancer medicine
Yaari, Z. A., da Silva, D., Zinger, A., Goldman, E., Kajal, A., Tshuva, R., Barak, E., Dahan, N., Hershkovitz, D., Goldfeder, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms13325 · Cited by 147
New Approaches to Molecular Diagnosis
Korf, B. R., & Rehm, H. L. (2013) · JAMA · doi:10.1001/jama.2013.3239 · Cited by 143
Integrative phenomics reveals insight into the structure of phenotypic diversity in budding yeastPreprint
Skelly, D. A., Merrihew, G. E., Riffle, M. E., Connelly, C. F., Kerr, E. O., Johansson, M., Jaschob, D., Graczyk, B., Shulman, N., Wakefield, J., et al. (2013) · Genome Research · doi:10.1101/gr.155762.113 · Cited by 146
Impact of direct-to-consumer genomic testing at long term follow-up
Bloss, C. S., Wineinger, N. E., Darst, B. F., Schork, N. J., & Topol, E. J. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101207 · Cited by 137
Internet-Based Direct-to-Consumer Genetic Testing: A Systematic Review
Covolo, L., Rubinelli, S., Ceretti, E., & Gelatti, U. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4378 · Cited by 132
Hamilton, J. G., Abdiwahab, E., Edwards, H. M., Fang, M.-L. E., Jdayani, A., & Breslau, E. S. (2016) · Journal of General Internal Medicine · doi:10.1007/s11606-016-3943-4 · Cited by 130
Green, K. M., & Stuart, E. A. (2014) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0036515 · Cited by 132
Consumer perceptions of direct-to-consumer personalized genomic risk assessments
Bloss, C. S., Ornowski, L., Silver, E., Cargill, M., Vanier, V., Schork, N. J., & Topol, E. J. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181eb51c6 · Cited by 122
Zhang, A., Sun, H. J., Wang, P., Han, Y., & Wang, X. (2011) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2011.10.007 · Cited by 121
Vo, A. Q., Zhang, J., Nyavanandi, D., Bandari, S., & Repka, M. A. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2020.116519 · Cited by 118
Lachance, C. R., Erby, L. H., Ford, B. M., Allen, V. C., & Kaphingst, K. A. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181dbd8b2 · Cited by 121
Taxonomizing, sizing, and overcoming the incidentalome
Kohane, I. S., Hsing, M., & Kong, S. W. (2012) · Genetics in Medicine · doi:10.1038/gim.2011.68 · Cited by 114
A Survey of UK Public Interest in Internet-Based Personal Genome Testing
Cherkas, L. F., Harris, J. M., Levinson, E., Spector, T. D., & Prainsack, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013473 · Cited by 109
Becker, F., van El, C. G., Ibarreta, D., Zika, E., Hogarth, S., Borry, P., Cambon‐Thomsen, A., Cassiman, J. J., Evers‐Kiebooms, G., Hodgson, S. V., et al. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.249 · Cited by 110
Implementation and utilization of genetic testing in personalized medicine
Scott, S., Abul-Husn, N., Owusu Obeng, A., Sanderson, S., & Gottesman, O. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s48887 · Cited by 106
Using Bayesian networks to discover relations between genes, environment, and disease
Su, C., Andrew, A. S., Karagas, M. R., & Borsuk, M. E. (2013) · BioData Mining · doi:10.1186/1756-0381-6-6 · Cited by 105
Direct-to-consumer genomic testing: systematic review of the literature on user perspectives
Goldsmith, L., Jackson, L. M., O’Connor, A., & Skirton, H. (2012) · European Journal of Human Genetics · doi:10.1038/ejhg.2012.18 · Cited by 95
Enterprising or altruistic selves? Making up research subjects in genetics research
Tutton, R., & Prainsack, B. (2011) · Sociology of Health & Illness · doi:10.1111/j.1467-9566.2011.01348.x · Cited by 90
Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility
Ye, B. D., & McGovern, D. P. B. (2016) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2016.1184972 · Cited by 92
Direct-to-consumer personalized genomic testing
Bloss, C. S., Darst, B. F., Topol, E. J., & Schork, N. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr349 · Cited by 89
Identifiability in biobanks: models, measures, and mitigation strategies
Malin, B., Loukides, G., Benitez, K., & Clayton, E. W. (2011) · Human Genetics · doi:10.1007/s00439-011-1042-5 · Cited by 85
Emerging technologies for hybridization based single nucleotide polymorphism detection
Knez, K., Spasić, D., Janssen, K. P. F., & Lammertyn, J. (2013) · The Analyst · doi:10.1039/c3an01436c · Cited by 76
Guelman, L., Guillén, M., & Marín, A. M. P. (2015) · Cybernetics & Systems · doi:10.1080/01969722.2015.1012892 · Cited by 75
Predicting phenotypic variation in yeast from individual genome sequences
Jelier, R., Semple, J. I., García-Verdugo, R., & Lehner, B. (2011) · Nature Genetics · doi:10.1038/ng.1007 · Cited by 76
Hughes, D. C., Day, S. H., Ahmetov, I. I., & Williams, A. G. (2011) · Journal of Sports Sciences · doi:10.1080/02640414.2011.597773 · Cited by 71
Bioinformatics for personal genome interpretation
Capriotti, E., Nehrt, N. L., Kann, M. G., & Bromberg, Y. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr070 · Cited by 68
Systems Biology Technologies Enable Personalized Traditional Chinese Medicine: A Systematic Review
Wang, X., Zhang, A., Sun, H. J., & Wang, P. (2012) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x12500826 · Cited by 66
Genomic Medicine: New Frontiers and New Challenges
Pasic, M. D., Samaan, S. F., & Yousef, G. M. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.184622 · Cited by 69
Personal genomics: information can be harmful
Ransohoff, D. F., & Khoury, M. J. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02232.x · Cited by 65
Singh, A., Ahmed, A., Sharma, A., & Arya, S. K. (2022) · Biosensors · doi:10.3390/bios12100910 · Cited by 65
Towards personalized care in IBD
Gerich, M. E., & McGovern, D. P. B. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.242 · Cited by 63
Blazer, K. R., MacDonald, D. J., Culver, J. O., Huizenga, C. R., Morgan, R. J., Uman, G. C., & Weitzel, J. N. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e31821882b7 · Cited by 63
Concordance Study of 3 Direct-to-Consumer Genetic-Testing Services
Imai, K., Kricka, L. J., & Fortina, P. M. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.158220 · Cited by 62
Keller, M., Gordon, E. S., Stack, C. B., Gharani, N., Sill, C. J., Schmidlen, T., Mintzer, J. L., Pallies, J., Gerry, N. P., & Christman, M. F. (2010) · Personalized Medicine · doi:10.2217/pme.10.13 · Cited by 61
Variations in predicted risks in personal genome testing for common complex diseases
Kalf, R. R. J., Mihăescu, R., Kundu, S., de Knijff, P., Green, R. C., & Janssens, A. C. J. W. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.80 · Cited by 61
Health-Care Referrals from Direct-to-Consumer Genetic Testing
Giovanni, M. A., Fickie, M. R., Lehmann, L. S., Green, R. C., Meckley, L. M., Veenstra, D. L., & Murray, M. F. (2010) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2010.0051 · Cited by 59
Genetic susceptibility testing for neurodegenerative diseases: Ethical and practice issues
Roberts, J. S., & Uhlmann, W. R. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.02.005 · Cited by 62
Genetic testing and common disorders in a public health framework
van El, C. G., & Cornel, M. C. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.176 · Cited by 57
McTavish, E. J., & Hillis, D. M. (2015) · BMC Genomics · doi:10.1186/s12864-015-1469-5 · Cited by 59
The Prospect of Genome‐guided Preventive Medicine: A Need and Opportunity for Genetic Counselors
O’Daniel, J. M. (2010) · Journal of Genetic Counseling · doi:10.1007/s10897-010-9302-4 · Cited by 54
the Utility of Genome-Wide Association Studies in Hepatology
Karlsen, T. H., Melum, E., & Franke, A. (2010) · Hepatology · doi:10.1002/hep.23564 · Cited by 56
Personalised Medicine, Individual Choice and the Common Good
van Beers, B. C., N, D. I. C. K. E. N. S. O., & Sterckx, S. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108590600 · Cited by 52
Bench-to-bedside: Translational development landscape of biotechnology in healthcare
Liao, C., Xiao, S., & Wang, X. (2023) · Health Sciences Review · doi:10.1016/j.hsr.2023.100097 · Cited by 54
MacDonald, D. J., Blazer, K. R., & Weitzel, J. N. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0046 · Cited by 52
Assessing Risk Factors as Potential Screening Tests
Wald, N., & Morris, J. K. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.378 · Cited by 48
Translational Bioinformatics: Linking the Molecular World to the Clinical World
Altman, R. B. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.49 · Cited by 50
Biological function through network topology: a survey of the human diseasome
Janjić, V., & Pržulj, N. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els037 · Cited by 50
Recent Developments of Electrochemical and Optical Biosensors for Antibody Detection
Xu, W., Wang, D., Li, D., & Liu, C.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010134 · Cited by 47
Direct-to-Consumer Personal Genome Testing and Cancer Risk Prediction
Bellcross, C. A., Page, P. Z., & Meaney‐Delman, D. M. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e3182610e38 · Cited by 45
Critchley, C. R., Nicol, D., Otlowski, M. F. A., & Chalmers, D. (2014) · Public Understanding of Science · doi:10.1177/0963662513519937 · Cited by 45
Cancer Risk Assessment Using Genetic Panel Testing: Considerations for Clinical Application
Hiraki, S. C., Rinella, E. S., Schnabel, F. R., Oratz, R., & D, H. O. M. (2014) · Journal of Genetic Counseling · doi:10.1007/s10897-014-9695-6 · Cited by 49
Translational Epidemiology in Psychiatry
Weissman, M. M., Brown, A. S., & Talati, A. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.47 · Cited by 43
Cui, L., Zhong, Y., Zhu, W. P., Xu, Y. F., & Qian, X. H. (2010) · Chemical Communications · doi:10.1039/c0cc01000f · Cited by 44
Advancements and applications of micro and nanostructured capacitive sensors: A review
Sakthivelpathi, V., Li, T., Qian, Z., Lee, C., Taylor, Z., & Chung, J. (2024) · Sensors and Actuators A Physical · doi:10.1016/j.sna.2024.115701 · Cited by 48
Khoury, M. J., Feero, W. G., & Valdez, R. A. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.03.019 · Cited by 42
Beyond clinical utility: The multiple values of DTC genetics
Turrini, M., & Prainsack, B. (2016) · Applied & Translational Genomics · doi:10.1016/j.atg.2016.01.008 · Cited by 42
Multigenic condition risk assessment in direct-to-consumer genomic services
Swan, M. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181d5f73b · Cited by 41
Genetic risk estimation in the Coriell Personalized Medicine Collaborative
Stack, C. B., Gharani, N., Gordon, E. S., Schmidlen, T., Christman, M. F., & Keller, M. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e318201164c · Cited by 41
Personalizing Medicine: Disease Prevention in silico and in socio
Green, S., & Vogt, H. (2016) · BIBSYS Brage (BIBSYS (Norway)) · Cited by 40
Liu, Y., Pham, X., Zhang, L., Chen, P.-L., Burzynski, G. M., McGaughey, D. M., He, S., McGrath, J. A., Wolyniec, P. S., Fallin, M. D., et al. (2014) · G3 Genes Genomes Genetics · doi:10.1534/g3.114.015636 · Cited by 41
Summarizing polygenic risks for complex diseases in a clinical whole-genome report
Kong, S. W., Lee, I., Leshchiner, I., Krier, J. B., Kraft, P. L., Rehm, H. L., Green, R. C., Kohane, I. S., & MacRae, C. A. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.143 · Cited by 39
Eng, C., & Sharp, R. R. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000214 · Cited by 39
23andMe, the Food and Drug Administration, and the Future of Genetic Testing
Zettler, P. J., Sherkow, J. S., & Greely, H. T. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.14706 · Cited by 38
Evaluating the accuracy of AIM panels at quantifying genome ancestry
Pardo‐Seco, J., Martinón‐Torres, F., & Salas, A. (2014) · BMC Genomics · doi:10.1186/1471-2164-15-543 · Cited by 40
Current State and Future Prospects of Direct-to-Consumer Pharmacogenetics
Chua, E. W., & Kennedy, M. A. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00152 · Cited by 37
Wu, S., Li, J., Mai, J., & Chang, M. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b08880 · Cited by 37
Words Matter: Distinguishing "Personalized Medicine" and "Biologically Personalized Therapeutics"
Cherny, N. I., de Vries, E. G. E., Emanuel, L., Fallowfield, L. J., Francis, P. A., Gabizon, A., Piccart, M. J., Sidransky, D., Soussan‐Gutman, L., & Tziraki, C. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju321 · Cited by 40
Genomics for Disease Treatment and Prevention
Bloss, C. S., Jeste, D. V., & Schork, N. J. (2010) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2010.11.005 · Cited by 38
San-Cristóbal, R., Milagro, F. I., & Martínez, J. A. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.05.028 · Cited by 36
Integration of omics sciences to advance biology and medicine
Boja, E. S., Kinsinger, C. R., Rodriguez, H., & Srinivas, P. R. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-45 · Cited by 38
Pharmacogenomics: The Importance of Accurate Phenotypes
Gurwitz, D., & Pirmohamed, M. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.41 · Cited by 34
Recent omics technologies and their emerging applications for personalised medicine
Kim, D., Kim, Y., Son, N., Kang, C., & Kim, A. (2017) · IET Systems Biology · doi:10.1049/iet-syb.2016.0016 · Cited by 38
Gulcher, J. R., & Stefánsson, K. (2009) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2009.02233.x · Cited by 33
Consuming genomes: scientific and social innovation in direct-to-consumer genetic testing
Curnutte, M., & Testa, G. (2012) · New Genetics and Society · doi:10.1080/14636778.2012.662032 · Cited by 31
Metadata
- Authors
- Ng, P. C., Murray, S. S., Levy, S., & Venter, J. C.
- Affiliations
- J. Craig Venter Institute (US)
- Venue
- Nature
- Published
- 2009-10
- Volume
- 461
- Issue
- 7265
- Pages
- 724-726
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2006204029
- Cited by
- 330
- References
- 20
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 6 · 2022: 6 · 2021: 5 · 2020: 12 · 2019: 13 · 2018: 23 · 2017: 7 · 2016: 11 · 2015: 23 · 2014: 29 · 2013: 32 · 2012: 48
- FWCI
- 34.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- personalized medicine, direct-to-consumer genetic testing, prediction accuracy, consumer genomics
- MeSH terms
- Ethnicity, False Negative Reactions, Female, Gene Frequency, Genetic Counseling, Genetic Markers, Genetic Testing, Genetics, Medical, Genotype, Humans, Male, Pharmacogenetics, Prospective Studies, Reproducibility of Results, Health Behavior, Genome, Human, Odds Ratio, Practice Guidelines as Topic, Sequence Analysis, DNA, Genetic Predisposition to Disease, Genome-Wide Association Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review